Seguir
Michael Heneka
Michael Heneka
University of Bonn
Dirección de correo verificada de ukbonn.de
Título
Citado por
Citado por
Año
Neuroinflammation in Alzheimer's disease
MT Heneka, MJ Carson, J El Khoury, GE Landreth, F Brosseron, ...
The Lancet Neurology 14 (4), 388-405, 2015
40712015
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
MT Heneka, MP Kummer, A Stutz, A Delekate, S Schwartz, ...
Nature 493 (7434), 674-678, 2013
20932013
Innate immune activation in neurodegenerative disease
MT Heneka, MP Kummer, E Latz
Nature Reviews Immunology 14 (7), 463-477, 2014
12022014
Inflammatory processes in Alzheimer's disease
MT Heneka, MK O'Banion
Journal of neuroimmunology 184 (1-2), 69-91, 2007
9172007
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice
MT Heneka, M Sastre, L Dumitrescu-Ozimek, A Hanke, I Dewachter, ...
Brain 128 (6), 1442-1453, 2005
6872005
Innate immunity in Alzheimer's disease
MT Heneka, DT Golenbock, E Latz
Nature immunology 16 (3), 229-236, 2015
6412015
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
G Kleinberger, Y Yamanishi, M Suárez-Calvet, E Czirr, E Lohmann, ...
Science translational medicine 6 (243), 243ra86-243ra86, 2014
6092014
Glial cells in (patho) physiology
V Parpura, MT Heneka, V Montana, SHR Oliet, A Schousboe, PG Haydon, ...
Journal of neurochemistry 121 (1), 4-27, 2012
5912012
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
C Venegas, S Kumar, BS Franklin, T Dierkes, R Brinkschulte, D Tejera, ...
Nature 552 (7685), 355-361, 2017
5722017
NLRP3 inflammasome activation drives tau pathology
C Ising, C Venegas, S Zhang, H Scheiblich, SV Schmidt, A Vieira-Saecker, ...
Nature 575 (7784), 669-673, 2019
5662019
Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists
C Grommes, GE Landreth, MT Heneka
The lancet oncology 5 (7), 419-429, 2004
5602004
Microglia in Alzheimer’s disease
H Sarlus, MT Heneka
The Journal of clinical investigation 127 (9), 3240-3249, 2017
5522017
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms
M Sastre, T Klockgether, MT Heneka
International Journal of Developmental Neuroscience 24 (2-3), 167-176, 2006
5062006
Neuroinflammatory processes in Alzheimer’s disease
MT Heneka, MK O’Banion, D Terwel, MP Kummer
Journal of neural transmission 117 (8), 919-947, 2010
4912010
Protective action of the peroxisome proliferator‐activated receptor‐γ agonist pioglitazone in a mouse model of Parkinson's disease
T Breidert, J Callebert, MT Heneka, G Landreth, JM Launay, EC Hirsch
Journal of neurochemistry 82 (3), 615-624, 2002
4722002
Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine
MT Heneka, F Nadrigny, T Regen, A Martinez-Hernandez, ...
Proceedings of the National Academy of Sciences 107 (13), 6058-6063, 2010
4712010
A guiding map for inflammation
MG Netea, F Balkwill, M Chonchol, F Cominelli, MY Donath, ...
Nature immunology 18 (8), 826-831, 2017
4622017
Nonsteroidal anti-inflammatory drugs repress β-secretase gene promoter activity by the activation of PPARγ
M Sastre, I Dewachter, S Rossner, N Bogdanovic, E Rosen, P Borghgraef, ...
Proceedings of the National Academy of Sciences 103 (2), 443-448, 2006
4562006
Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation
T Dehmer, MT Heneka, M Sastre, J Dichgans, JB Schulz
Journal of neurochemistry 88 (2), 494-501, 2004
4402004
Inflammasome signalling in brain function and neurodegenerative disease
MT Heneka, RM McManus, E Latz
Nature Reviews Neuroscience 19 (10), 610-621, 2018
4232018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20